Antiretroviral treatment uptake in patients with HIV-associated TB attending co-located TB and ART services

South African Medical Journal

Volumn 102, Issue 12, 2012, Pages 936-939

  Nglazi, M D ^a,b   Kaplan, R ^a   Caldwell, J ^c   Peton, N ^d   Lawn, S D ^a,e   Wood, R ^a   Bekker, L G ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^c City of Cape Town   (South Africa)

^d WESTERN CAPE DEPARTMENT OF AGRICULTURE   (South Africa)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; DEATH; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; HEALTH CARE DELIVERY; HEALTH SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; RETROSPECTIVE STUDY; RISK FACTOR; SOUTH AFRICA; TUBERCULOSIS;

ADULT; ANTI-HIV AGENTS; ANTITUBERCULAR AGENTS; FEMALE; HIV INFECTIONS; HUMANS; LOST TO FOLLOW-UP; MALE; PATIENT ADMISSION; RETROSPECTIVE STUDIES; SOUTH AFRICA; TIME FACTORS; TREATMENT OUTCOME; TUBERCULOSIS; YOUNG ADULT;

EID: 84870679217     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: 10.7196/SAMJ.6024     Document Type: Article

References (24)

1. World Health Organization. Global HIV/AIDS response: Epidemic Update and Health Sector Progress towards Universal Access. Progress Report 2011. Geneva: World Health Organization, 2011. http://whqlibdoc.who.int/publications/2011/9789241502986_eng.pdf (accessed 8 March 2012).
2. Lawn SD, Zumla AI. Tuberculosis. Lancet 2011;378(9785):57-72. [http://dx.doi.org/10.1016/S0140-6736(10)62173-3] [PMID:21420161]
3. World Health Organization. Global Tuberculosis Control. Geneva: World Health Organization, 2011. http://www.who.int/tb/publications/global_report/2011/gtbr11_full.pdf (accessed 15 May 2012).
4. Bekker L-G, Wood R. TB and HIV co-infection: When to start antiretorviral therapy. S Afr J Contin Med Educ 2011;29(10):420-426.
5. Lawn SD, Kranzer K, Wood R. Antiretroviral therapy for control of the HIV-associated tuberculosis epidemic in resource-limited settings. Clin Chest Med 2009;30(4):685-699. [http://dx.doi.org/10.1016/j.ccm.2009.08.010] [PMID:19925961] [PMCID:PMC2887494]
6. Abdool Karim SS, Naidoo K, Grobler A, et al. Timing of initiation of antiretroviral drugs during tuberculosis therapy. N Engl J Med 2010;362(8):697-706. [http://dx.doi.org/10.1056/NEJMoa0905848] [PMID: 20181971] [PMCID:PMC3076221]
7. Abdool Karim SS, Naidoo K, Padayatchi N, et al. Optimal timing of ART during TB therapy; findings of the SAPIT trial. 18th Conference on Retroviruses and Opportunistic Infections, Boston, MA, USA. Abstract 39LB. 2011.
8. Blanc FX, Sok T, Laureillard D, et al. Significant enhancement in survival with early (2 weeks) v. late (8 weeks) initiation of highly active antiretroviral treatment (HAART) in severely immunosuppressed HIV-infected adults with newly diagnosed tuberculosis. AIDS 2010 - XVIII International AIDS Conference, Austria, Vienna. Abstract no. THLBB106. 2010.
9. Havlir DV, Kendall MA, Ive P, et al. Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N Engl J Med 2011;365(16):1482-1491. [http://dx.doi.org/10.1056/NEJMoa1013607] [PMID:22010914] [PMCID:PMC3327101]
10. World Health Organization. Antiretroviral Therapy for HIV Infection in Adults and Adolescents. Recommendations for a Public Health Approach (2010 revision). Geneva: World Health Organization, 2010. http://www.who.int/hiv/pub/arv/adult/en/index.html (accessed 14 February 2012).
11. World Health Organization. Priority Research Questions for Tuberculosis/Human Immunodeficiency Virus (TB/HIV) in HIV-prevalent and Resource-limited Settings. Geneva: World Health Organization, 2010.
12. World Health Organization. WHO Policy on Collaborative TB/HIV Activities: Guidelines for National Programmes and other Stakeholders. Geneva: World Health Organization, 2012. http://whqlibdoc.who.int/publications/2012/9789241503006_eng.pdf (accessed 22 May 2012).
13. Zachariah R, Harries AD, Manzi M, et al. Acceptance of anti-retroviral therapy among patients infected with HIV and tuberculosis in rural Malawi is low and associated with cost of transport. PLoS One 2006;1(1):e121. [http://dx.doi.org/10.1371/journal.pone.0000121] [PMID:17205125][PMCID:PMC1762339]
14. Brown C, Kerschberger B, Boulle A, et al. TB and HIV service integration within a South African primary health care setting reduces the time to ART initiation without negatively impacting TB outcomes. 18th Conference on Retroviruses and Opportunistic Infections, Boston, USA. Abstract 890. 2011.
15. Lawn SD, Campbell L, Kaplan R, et al. Time to initiation of antiretroviral therapy among patients with HIV-associated tuberculosis in Cape Town, South Africa. J Acquir Immune Defic Syndr 2011;57(2):136. [http://dx.doi.org/10.1097/QAI.0b013e3182199ee9] [PMID:21436714]
16. Lawn SD, Campbell L, Kaplan R, Little F, Morrow C, Wood R. Delays in starting antiretroviral therapy in patients with HIV-associated tuberculosis accessing non-integrated clinical services in a South African township. BMC Infect Dis 2011;11:258. [http://dx.doi.org/10.1186/1471-2334-11-258] [PMID:21957868] [PMCID:PMC3203070]
17. Pepper DJ, Marais S, Wilkinson RJ, Bhaijee F, De Azevedo V, Meintjes G. Barriers to initiation of antiretrovirals during antituberculosis therapy in Africa. PLoS One. 2011;6(5):e19484. [http://dx.doi.org/10.1371/journal.pone.0019484] [PMID:21589868] [PMCID:PMC3093394]
18. Hermans SM, Castelnuovo B, Kambugu A, Lange JMA, Hoepelman AIM, Manabe YC. Integration of HIV and TB services results in earlier and more prioritised ART initiation in Uganda. 6th IAS Conference on HIV Pathogenesis and Treatment, Rome, Italy. Abstract WEPDD0103. 2011.
19. Statistics South Africa Mid-year Population Estimates. Department of Health, South Africa. Pretoria: Statistics South Africa, 2010. http://www.statssa.gov.za/publications/P0302/P03022010.pdf (accessed 18 August 2011).
20. National Department of Health. 2009 National Antenatal Sentinel HIV and Syphilis Prevalence Survey, South Africa. Pretoria: National Department of Health, 2010.
21. National Department of Health. The South African National Tuberculosis Control Programme Practical Guidelines 2004. Pretoria: National Department of Health, 2004.
22. National Department of Health. National Antiretroviral Treatment Guidelines. Pinetown, South Africa: Jacana Publishers, 2004.
23. National Department of Health. Clinical Guidelines for the Management of HIV&AIDS in Adults and Adolescents. Pretoria: National Department of Health, 2010.
24. Daftary A, Padayatchi N. Social constraints to TB/HIV healthcare: Accounts from coinfected patients in South Africa. AIDS Care 2012; 24 April. [http://dx.doi.org/10.1080/09540121.2012.672719] [PMID:22530855]